Indeed, Krause and colleagues were recently able to show that candidemic patients have significantly higher IL-17A plasma levels in comparison to non-candidemic patients [91], thus suggesting a potential role of IL-17A for the anticipation of invasive candidiasis. This evidence concerns the gene IL17A and candidiasis.